Tips for managing GLP-1 and GIP weight-loss medications during the holidays without derailing progress.
The holiday season often revolves around food, drink, and gatherings with family and friends—factors that can complicate the routines of those on weight-loss medications like Wegovy, Ozempic, and Mounjaro. These drugs, designed to suppress appetite by targeting GLP-1 and GIP hormones, require consistent dosing schedules to be effective. However, the temptation to adjust injections to accommodate big meals can backfire, experts warn.
Andre Teixeira, a bariatric specialist at Orlando Health. "Some people never tolerate the higher doses again after stopping," he notes, likening the hormonal effects to side effects some women experience when switching birth control methods.Experts agree that the key to enjoying holiday meals and traditions while staying on track with weight-loss medications lies in preparation and moderation.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA saysIt is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.
Read more »
Ozempic, Wegovy move closer to no longer being in shortage, FDA saysAll doses of the weight loss drugs are listed as 'available' by the FDA.
Read more »
How a love story launched the company behind Ozempic, WegovyNovo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
Read more »
Ozempic, Wegovy Could Help Ease Knee Arthritis PainThe GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.
Read more »
Ozempic, Wegovy ingredient may lower risk of Alzheimer’s, study findsAn active ingredient in Ozempic and Wegovy may help to lower the risk of — or even prevent —
Read more »
FDA adds warning to Ozempic, WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Read more »